Gr Sarantis (SAR) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
10 Nov, 2026Executive summary
9M 2026 sales grew 1.2%, supported by priority categories, HERO brands and portfolio management; underlying profitability remained solid.
Continued investment in international brand expansion, digital transformation and manufacturing capabilities amid a challenging market environment.
Financial highlights
Net sales were €453.7m vs €448.5m in 9M 2025, up 1.2%.
Underlying EBITDA was €67.8m vs €68.0m in 9M 2025; underlying EBIT was €49.9m vs €51.7m.
Net debt was €12.0m at 30 September 2026 vs €4.9m a year earlier.
Outlook and guidance
FY 2026 net sales expected at €610m, up 1.7% vs 2025.
FY 2026 underlying EBITDA expected at €91m, up 2.2% vs 2025; underlying EBIT expected at €67m, flat vs 2025.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Gr Sarantis
- Record sales and sharply higher profit, with net cash supporting growth and acquisitions.SAR
H2 2023 - Revenue up 1.3% to €308.3m, net profit down 5.1%, HERO brands and digital drive growth.SARH1 2026
- Q1 2026 delivered strong sales and margin growth, driven by mix, efficiency, and expansion.SARQ1 2026 TU
- EBITDA and net income surged in 2025, led by branded and beauty growth and global expansion.SARH2 2025
- Profitability rose despite a slight sales dip, driven by margin expansion and US growth initiatives.SARQ3 2025 TU
- Net profit up 20% to €29.2m on 0.5% sales growth, led by Beauty, Skin & Sun Care.SARH1 2025
- Net sales surged 27.9% to €452.0m, with margin gains and strong Stella Pack integration.SARQ3 2024 TU
- Record H1 sales and profit growth, fueled by Stella Pack and strong margin expansion.SARH1 2024
- Record sales and profit growth in 2024, with further gains and investments forecast for 2025.SARH2 2024